Patent Assignment
Reel/Frame 052912/0929
Assignment of Assignor's Interest
Recorded: 2020-06-11
Pages: 8
Assignor
INHIBRX, LP
Executed: 2020-02-06
Assignee
INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(4)
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Multivalent and Multispecific Glucocorticoid-Induced Tnfr-Related Protein (Gitr)-Binding Single-Domain Antibody Fusion Proteins and Encoding Nucleic Acids
Serpin Fusion Polypeptides and Methods of Use Thereof
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 11, 2015
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 035610/0709 →
Change of Name
Nov 28, 2017
From: INHIBRX LLC
To: INHIBRX LP
Reel/Frame 044528/0712 →
Assignment of Assignor's Interest
Jan 24, 2018
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 044710/0285 →
Assignment of Assignor's Interest
Jan 25, 2018
From: INHIBRX LLC
To: INHIBRX LP
Reel/Frame 045150/0827 →
Assignment of Assignor's Interest
Apr 30, 2019
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 049033/0761 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded at Reel: 045150 Frame: 0827. Assignor(S) Hereby Confirms the Change of Name.
May 15, 2019
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 049181/0754 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Change of Name
Aug 22, 2024
From: INHIBRX, INC.
To: SANOFI AATD INC.
Reel/Frame 068752/0666 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →